Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment.

[1]  M. White,et al.  Impact of better adherence to statin agents in the primary prevention of coronary artery disease , 2009, European Journal of Clinical Pharmacology.

[2]  M. Böhm,et al.  Effect of Chronic Statin Pretreatment on Hospital Outcome in Patients With Acute Non-ST-Elevation Myocardial Infarction , 2009, Journal of cardiovascular pharmacology.

[3]  R. Kornowski,et al.  Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. , 2009, The American journal of cardiology.

[4]  G. Chodick,et al.  Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. , 2008, Clinical therapeutics.

[5]  T. Trikalinos,et al.  Statins, low-density lipoprotein cholesterol, and risk of cancer. , 2008, Journal of the American College of Cardiology.

[6]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[7]  Wiley Chan,et al.  Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update. , 2007, American heart journal.

[8]  R. Califf,et al.  Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials. , 2007, American heart journal.

[9]  M. Simoons,et al.  Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. , 2006, European heart journal.

[10]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[11]  A. Laupacis,et al.  Effect of age on the use of evidence-based therapies for acute myocardial infarction. , 2004, American heart journal.

[12]  B. Lewis,et al.  General cardiology: abstractImportance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients , 2004 .

[13]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[14]  J. Gurwitz,et al.  Age-Specific Differences in the Use of Thrombolytic Therapy and Hospital Outcomes in Patients with Acute Myocardial Infarction: A Community-Wide Perspective , 2002, Journal of Thrombosis and Thrombolysis.

[15]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[16]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[17]  J. LeLorier,et al.  Do statins cause cancer? A meta-analysis of large randomized clinical trials. , 2001, The American journal of medicine.

[18]  L. Wallentin,et al.  Early statin treatment following acute myocardial infarction and 1-year survival. , 2001, JAMA.

[19]  A. Weverling-Rijnsburger,et al.  Total cholesterol and risk of mortality in the oldest old , 1997, The Lancet.

[20]  P. Loehrer.  Statins and Cancer Risk: A Meta-analysis , 2007 .

[21]  M. Clearfield.  Mortality and incidence of cancer during 10-year follow-up of the Scandinavian simvastatin survival study. , 2005, Current atherosclerosis reports.

[22]  Á. Avezum,et al.  Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). , 2005, American heart journal.

[23]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .